It is noteworthy that a viral toxicity therapy based on the intravenous injection of the osteocalcin promoter was observed to significantly inhibit the growth of osteosarcoma lung metastases and significantly improve survival in animal experiments (99). The gene discussed is BGLAP; the disease is osteosarcoma.